Logo image of CBV.CA

COBRA VENTURE CORP (CBV.CA) Stock Fundamental Analysis

TSX-V:CBV - TSX Venture Exchange - CA19104W1041 - Common Stock - Currency: CAD

0.125  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CBV. CBV was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. CBV has a great financial health rating, but its profitability evaluates not so good. CBV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CBV had negative earnings in the past year.
In the past year CBV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CBV reported negative net income in multiple years.
In the past 5 years CBV always reported a positive cash flow from operatings.
CBV.CA Yearly Net Income VS EBIT VS OCF VS FCFCBV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K -1M -1.5M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.13%, CBV is in line with its industry, outperforming 43.40% of the companies in the same industry.
CBV has a Return On Equity (-4.32%) which is in line with its industry peers.
CBV has a Return On Invested Capital (0.20%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.13%
ROE -4.32%
ROIC 0.2%
ROA(3y)1.76%
ROA(5y)0.44%
ROE(3y)1.88%
ROE(5y)0.47%
ROIC(3y)N/A
ROIC(5y)N/A
CBV.CA Yearly ROA, ROE, ROICCBV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

CBV has a Operating Margin of 0.59%. This is comparable to the rest of the industry: CBV outperforms 44.81% of its industry peers.
CBV has a Gross Margin of 44.78%. This is in the better half of the industry: CBV outperforms 69.34% of its industry peers.
In the last couple of years the Gross Margin of CBV has remained more or less at the same level.
Industry RankSector Rank
OM 0.59%
PM (TTM) N/A
GM 44.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.24%
GM growth 5Y1.39%
CBV.CA Yearly Profit, Operating, Gross MarginsCBV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBV is destroying value.
The number of shares outstanding for CBV remains at a similar level compared to 1 year ago.
The number of shares outstanding for CBV has been increased compared to 5 years ago.
There is no outstanding debt for CBV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CBV.CA Yearly Shares OutstandingCBV.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CBV.CA Yearly Total Debt VS Total AssetsCBV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

CBV has an Altman-Z score of 10.66. This indicates that CBV is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 10.66, CBV belongs to the best of the industry, outperforming 92.45% of the companies in the same industry.
CBV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.66
ROIC/WACC0.02
WACC8.04%
CBV.CA Yearly LT Debt VS Equity VS FCFCBV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

CBV has a Current Ratio of 42.65. This indicates that CBV is financially healthy and has no problem in meeting its short term obligations.
CBV's Current ratio of 42.65 is amongst the best of the industry. CBV outperforms 99.53% of its industry peers.
CBV has a Quick Ratio of 42.65. This indicates that CBV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 42.65, CBV belongs to the top of the industry, outperforming 99.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 42.65
Quick Ratio 42.65
CBV.CA Yearly Current Assets VS Current LiabilitesCBV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

CBV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -360.71%.
The Revenue has decreased by -1.88% in the past year.
Measured over the past years, CBV shows a decrease in Revenue. The Revenue has been decreasing by -1.48% on average per year.
EPS 1Y (TTM)-360.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.19%
Revenue 1Y (TTM)-1.88%
Revenue growth 3Y-6.83%
Revenue growth 5Y-1.48%
Sales Q2Q%27.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBV.CA Yearly Revenue VS EstimatesCBV.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CBV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBV.CA Price Earnings VS Forward Price EarningsCBV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBV is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 169.57
EV/EBITDA -0.95
CBV.CA Per share dataCBV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CBV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COBRA VENTURE CORP

TSX-V:CBV (6/24/2025, 7:00:00 PM)

0.125

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners45.08%
Ins Owner ChangeN/A
Market Cap2.07M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-367.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.52
P/FCF 169.57
P/OCF 55.91
P/B 0.73
P/tB 0.73
EV/EBITDA -0.95
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.59%
OCF(TTM)0
OCFY1.79%
SpS0.08
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.13%
ROE -4.32%
ROCE 0.28%
ROIC 0.2%
ROICexc 0.88%
ROICexgc 0.88%
OM 0.59%
PM (TTM) N/A
GM 44.78%
FCFM 0.9%
ROA(3y)1.76%
ROA(5y)0.44%
ROE(3y)1.88%
ROE(5y)0.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.24%
GM growth 5Y1.39%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 14.06%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 20.14%
Profit Quality N/A
Current Ratio 42.65
Quick Ratio 42.65
Altman-Z 10.66
F-Score5
WACC8.04%
ROIC/WACC0.02
Cap/Depr(3y)38.23%
Cap/Depr(5y)38.53%
Cap/Sales(3y)5.25%
Cap/Sales(5y)6.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-360.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.88%
Revenue growth 3Y-6.83%
Revenue growth 5Y-1.48%
Sales Q2Q%27.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-97.4%
FCF growth 3Y-39.04%
FCF growth 5YN/A
OCF growth 1Y-94.22%
OCF growth 3Y-35.4%
OCF growth 5Y-10.28%